Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak – 29 June 2021
Jennifer Wang, Anjana Pillai – 28 June 2021
Neehar D. Parikh, Kyle Cuneo, Mishal Mendiratta‐Lala – 28 June 2021
Amit G. Singal – 28 June 2021
Hatef Massoumi – 28 June 2021
Davide Cussa, Claudia Borbon, Andrea Novaresio, Silvia Catalano, Guglielmo Ramieri, Francesco Tandoi, Renato Romagnoli – 27 June 2021
Wayne Bai, Mustafa Al‐Karaghouli, Jesse Stach, Shuen Sung, Granville J. Matheson, Juan G. Abraldes – 27 June 2021
Pusen Wang, Lin Zhong – 26 June 2021
Alyson Kaplan, Russell Rosenblatt, Benjamin Samstein, Robert S. Brown – 25 June 2021 – Living donor liver transplantation (LDLT) is a vital tool to address the growing organ shortage in the United States caused by increasing numbers of patients diagnosed with end‐stage liver disease. LDLT still only makes up a very small proportion of all liver transplantations performed each year, but there are many innovations taking place in the field that may increase its acceptance among both transplant programs and patients.